【Abstract】ObjectiveTo detect the expression of melanoma antigen-3 gene (MAGE-3) in rectal cancer and explore its relationship with the clinical pathology of rectal cancer and clinical significance in immune therapy.
MethodsThe expressions of MAGE-3 in tumor tissue, para-tumor tissue of （5±1） cm from border of tumor tissue, tissue of resection border and polypus were detected by RTPCR.
ResultsMAGE-3 expression was positive in 14 of 33(42.42%) samples of rectal cancer, 6 of 33 (18.18%) of paratumor tissue, and 5 of 33 (15.15%) of resection border tissue respectively. No MAGE-3 was detected in 3 polypi. The positive rate of MAGE-3 in tumor tissue was significantly higher than that of the paratumor and resection border tissue (P＜0.05). The expression of MAGE-3 was not related to age, gender, histological type, metastasis to lymph nodes, and Dukes stage (P gt;0.05).
Conclusion MAGE-3 protein may be used as a target of immunotherapy for rectal cancer and an index for follow-up and screening of rectal cancer.
Citation：
LI Xin ming,TAO Kaixiong,WANG Guobin,ZHANG Ning,WU Xiangbo,ZHANG Jinghui,TIAN Yuan.. Expression and Clinical Significance of Melanoma Antigen-3 Gene in Rectal Cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(3): 308-310下转320. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
[Ｊ]. Int J Cancer, 2003; 104(4)∶ 482.
|
| 2. |
[Ｊ]. Clin Cancer Res, 2003； 9(7)∶2447.
|
| 3. |
|
| 4. |
[Ｊ]. Nihon Rinsho Meneki Gakkai Kaishi, 1997； 20(2)∶95.
|
| 5. |
[Ｊ]. J Korean Med Sci， 2002; 17(4)∶497.
|
| 6. |
[Ｊ]. Arch Pathol Lab Med, 1998； 122(6)∶551.
|
| 7. |
|
| 8. |
[Ｊ]. Ann Surg, 1996； 224(2)∶183.
|
| 9. |
[Ｊ]. Cancer Lett， 2004; 208(2)∶197.
|
| 10. |
Eichmuller S, Usener D, Thiel D, et al. Tumorspecific antigens in cutaneous Tcell lymphoma: expression and seroreactivity.
|
| 11. |
Ullenhag GJ, Frodin JE, Mosolits S, et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen EpCAM/KSA (ALVACKSA) and granulocyte macrophage colonystimulating factor induced a tumorspecific cellular immune response.
|
| 12. |
Nishimura S, Fujita M, Terata N, et al. Expression of MAGE genes in colorectal carcinomas.
|
| 13. |
Park MS, Park JW, Jeon CH, et al. Expression of melanoma antigenencoding genes (MAGE) by common primers for MAGEA1 toA6 in colorectal carcinomas among Koreans.
|
| 14. |
Hasegawa H, Mori M, Haraguchi M, et al. Expression spectrum of melanoma antigenencoding gene family members in colorectal carcinoma.
|
| 15. |
Mori M, Inoue H, Mimori K, et al. Expression of MAGE genes in human colorectal carcinoma.
|
| 16. |
Gerhardt A, Usener D, Keese M, et al. Tissue expression and seroreactivity of tumorspecific antigens in colorectal cancer.
|
- 1. [Ｊ]. Int J Cancer, 2003; 104(4)∶ 482.
- 2. [Ｊ]. Clin Cancer Res, 2003； 9(7)∶2447.
- 3.
- 4. [Ｊ]. Nihon Rinsho Meneki Gakkai Kaishi, 1997； 20(2)∶95.
- 5. [Ｊ]. J Korean Med Sci， 2002; 17(4)∶497.
- 6. [Ｊ]. Arch Pathol Lab Med, 1998； 122(6)∶551.
- 7.
- 8. [Ｊ]. Ann Surg, 1996； 224(2)∶183.
- 9. [Ｊ]. Cancer Lett， 2004; 208(2)∶197.
- 10. Eichmuller S, Usener D, Thiel D, et al. Tumorspecific antigens in cutaneous Tcell lymphoma: expression and seroreactivity.
- 11. Ullenhag GJ, Frodin JE, Mosolits S, et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen EpCAM/KSA (ALVACKSA) and granulocyte macrophage colonystimulating factor induced a tumorspecific cellular immune response.
- 12. Nishimura S, Fujita M, Terata N, et al. Expression of MAGE genes in colorectal carcinomas.
- 13. Park MS, Park JW, Jeon CH, et al. Expression of melanoma antigenencoding genes (MAGE) by common primers for MAGEA1 toA6 in colorectal carcinomas among Koreans.
- 14. Hasegawa H, Mori M, Haraguchi M, et al. Expression spectrum of melanoma antigenencoding gene family members in colorectal carcinoma.
- 15. Mori M, Inoue H, Mimori K, et al. Expression of MAGE genes in human colorectal carcinoma.
- 16. Gerhardt A, Usener D, Keese M, et al. Tissue expression and seroreactivity of tumorspecific antigens in colorectal cancer.
